Larvol Delta - Trastuzumab-Duocarmazine-in-Pretreated-Human-Epidermal-Growth-Factor-Receptor-2Positive-Advanced-or-Metastatic-Breast-Cancer-An-OpenLabel-Randomized-Phase-III-Trial-TULIP

Jivadco (trastuzumab duocarmazine) - Byondis, Medac

https://ascopubs.org/doi/10.1200/JCO.24.00529

Oct 23, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next